Literature DB >> 7039712

Bromocriptine and insulin secretion.

E E El-Denshary, N A Ismail, E Gagerman, J Sehlin, I B Täljedal.   

Abstract

The dopaminergic drug bromocriptine inhibited the release of insulin from isolated mouse pancreatic islets. The effect was counteracted by haloperidol or pimozide. It is suggested that insulin release may be inhibited through activation of D-2 dopaminergic receptors in the pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7039712     DOI: 10.1007/bf01116177

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  4 in total

1.  Effect of domperidone on the release of insulin after intravenous glucose load in man.

Authors:  A Pezzarossa; P P Vescovi; C Cervigni; O Angelini; M C Cimicchi; L Capretti; G Campana; U Butturini
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

2.  Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity.

Authors:  M Maccario; S Grottoli; M Procopio; S E Oleandri; A Barberis; E Ciccarelli; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

3.  Inhibition of ATP-sensitive potassium channels by haloperidol.

Authors:  Shi-Bing Yang; Peter Proks; Frances M Ashcroft; Marjan Rupnik
Journal:  Br J Pharmacol       Date:  2004-11-08       Impact factor: 8.739

4.  Bromocriptine-induced hyperglycemia in nonobese diabetic mice: kinetics and mechanisms of action.

Authors:  Sylvie Durant; Josiane Coulaud; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2007-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.